AB.PA
AB Science SA
Price:  
0.78 
EUR
Volume:  
30,182.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-194.4%
Upside

As of 2024-12-12, the EV/EBITDA ratio of AB Science SA (AB.PA) is -13.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 55.02 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -3.98 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.1x - 8.3x 8.2x
Forward P/E multiples 7.6x - 10.3x 8.2x
Fair Price (0.69) - (0.74) (0.74)
Upside -189.1% - -194.9% -194.4%
0.78 EUR
Stock Price
(0.74) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-10 -13.82
2024-12-09 -13.91
2024-12-06 -13.79
2024-12-05 -13.99
2024-12-04 -14.02
2024-12-03 -13.89
2024-12-02 -13.96
2024-11-29 -14.12
2024-11-28 -14.33
2024-11-27 -14.40
2024-11-26 -13.75
2024-11-25 -13.96
2024-11-22 -14.11
2024-11-21 -13.96
2024-11-20 -14.43
2024-11-19 -14.99
2024-11-18 -15.27
2024-11-15 -15.46
2024-11-14 -15.43
2024-11-13 -15.95
2024-11-12 -16.11
2024-11-11 -16.26
2024-11-08 -16.13
2024-11-07 -16.68
2024-11-06 -16.66
2024-11-05 -16.52
2024-11-04 -17.16
2024-11-01 -17.25
2024-10-31 -17.22
2024-10-30 -16.68
2024-10-29 -16.75
2024-10-28 -16.37
2024-10-25 -16.72
2024-10-24 -16.78
2024-10-23 -16.43
2024-10-22 -16.52
2024-10-21 -16.07
2024-10-18 -16.58
2024-10-17 -16.43
2024-10-16 -16.71
2024-10-15 -16.61
2024-10-14 -16.72
2024-10-11 -16.62
2024-10-10 -16.56
2024-10-09 -16.53
2024-10-08 -16.33
2024-10-07 -16.56
2024-10-04 -16.80
2024-10-03 -16.75
2024-10-02 -16.58